ArticleHeliyon2024

Prognostic value of body mass index for first-line chemoimmunotherapy combinations in advanced non-small cell lung cancer in Chinese population.

Yanxin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.